Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radiofrequency ablation of cancer.

Literature DB >> 15383844

Radiofrequency ablation of cancer.

Marc Friedman¹, Igor Mikityansky, Anthony Kam, Steven K Libutti, McClellan M Walther, Ziv Neeman, Julia K Locklin, Bradford J Wood.

Abstract

Radiofrequency ablation (RFA) has been used for over 18 years for treatment of nerve-related chronic pain and cardiac arrhythmias. In the last 10 years, technical developments have increased ablation volumes in a controllable, versatile, and relatively inexpensive manner. The host of clinical applications for RFA have similarly expanded. Current RFA equipment, techniques, applications, results, complications, and research avenues for local tumor ablation are summarized.

Entities: Disease

Mesh：

Year: 2004 PMID： 15383844 PMCID： PMC2408956 DOI： 10.1007/s00270-004-0062-0

Source DB: PubMed Journal: Cardiovasc Intervent Radiol ISSN： 0174-1551 Impact factor: 2.740

63 in total

1. Hepatic ablation using radiofrequency electrocautery.

Authors: J P McGahan; P D Browning; J M Brock; H Tesluk
Journal: Invest Radiol Date: 1990-03 Impact factor: 6.016

2. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases.

Authors: T Livraghi; S N Goldberg; F Monti; A Bizzini; S Lazzaroni; F Meloni; S Pellicanò; L Solbiati; G S Gazelle
Journal: Radiology Date: 1997-01 Impact factor: 11.105

3. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.

Authors: S Rossi; M Di Stasi; E Buscarini; P Quaretti; F Garbagnati; L Squassante; C T Paties; D E Silverman; L Buscarini
Journal: AJR Am J Roentgenol Date: 1996-09 Impact factor: 3.959

4. Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver.

Authors: W J Wiersinga; M C Jansen; I H Straatsburg; P H Davids; J M Klaase; D J Gouma; T M van Gulik
Journal: Br J Surg Date: 2003-03 Impact factor: 6.939

5. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.

Authors: Gregory S Anderson; Frank Brinkmann; Michael C Soulen; Abass Alavi; Hongming Zhuang
Journal: Clin Nucl Med Date: 2003-03 Impact factor: 7.794

6. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver.

Authors: S Rossi; F Fornari; C Pathies; L Buscarini
Journal: Tumori Date: 1990-02-28

Review 7. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.

Authors: Jackson Sai-Yiu Wu; Rebecca Wong; Mary Johnston; Andrea Bezjak; Timothy Whelan
Journal: Int J Radiat Oncol Biol Phys Date: 2003-03-01 Impact factor: 7.038

8. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization.

Authors: Mikiya Kitamoto; Masaru Imagawa; Hiroyasu Yamada; Chiyuki Watanabe; Masaaki Sumioka; Osamu Satoh; Masaru Shimamoto; Michiyo Kodama; Shojiro Kimura; Keiko Kishimoto; Yuzo Okamoto; Yasuhiko Fukuda; Kiyohiko Dohi
Journal: AJR Am J Roentgenol Date: 2003-10 Impact factor: 3.959

9. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study.

Authors: Tito Livraghi; Luigi Solbiati; M Franca Meloni; G Scott Gazelle; Elkan F Halpern; S Nahum Goldberg
Journal: Radiology Date: 2003-02 Impact factor: 11.105

10. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors.

Authors: Debra A Gervais; Francis J McGovern; Ronald S Arellano; W Scott McDougal; Peter R Mueller
Journal: Radiology Date: 2003-02 Impact factor: 11.105

16 in total

Review 1. Radiofrequency energy in surgery: state of the art.

Authors: Peter Ihnát; Lucia Ihnát Rudinská; Pavel Zonča
Journal: Surg Today Date: 2013-06-01 Impact factor: 2.549

Review 2. Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.

Authors: Serge Ginzburg; Jeffrey J Tomaszewski; Alexander Kutikov
Journal: Nat Rev Urol Date: 2017-09-12 Impact factor: 14.432

Review 3. Complications of microwave and radiofrequency lung ablation: personal experience and review of the literature.

Authors: G Carrafiello; M Mangini; F Fontana; A Di Massa; A M Ierardi; E Cotta; F Piacentino; L Nocchi Cardim; C Pellegrino; C Fugazzola
Journal: Radiol Med Date: 2011-10-21 Impact factor: 3.469

4. Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing.

Authors: Ashley R Hoover; Kaili Liu; Christa I DeVette; Jason R Krawic; Alexandra D Medcalf; Connor L West; Tomas Hode; Samuel S K Lam; Alana L Welm; Xiao-Hong Sun; William H Hildebrand; Wei R Chen
Journal: Clin Transl Med Date: 2022-07

5. Current oncologic applications of radiofrequency ablation therapies.

Authors: Dhruvil R Shah; Sari Green; Angelina Elliot; John P McGahan; Vijay P Khatri
Journal: World J Gastrointest Oncol Date: 2013-04-15

6. Magnetic resonance imaging of time-varying magnetic fields from therapeutic devices.

Authors: Luis Hernandez-Garcia; Vivek Bhatia; Krishan Prem-Kumar; Magnus Ulfarsson
Journal: NMR Biomed Date: 2013-01-28 Impact factor: 4.044

7. Radiopharmaceutical study on Iodine-131-labelled hypericin in a canine model of hepatic RFA-induced coagulative necrosis.

Authors: Xiaojun Qi; Haibo Shao; Jian Zhang; Ziping Sun; Yicheng Ni; Ke Xu
Journal: Radiol Med Date: 2014-07-11 Impact factor: 3.469